Jamison Strahan, MD
MOHS-Micrographic Surgery · Centennial, CONPI 1578600839
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $763, 7.9 times the $97 reported in 2019.
Across 104 payments — averaging $27.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$459
- AbbVie$451
- Johnson & Johnson$354
- Lilly USA, LLC$204
- Sun Pharmaceutical Industries Inc.$199
- Galderma Laboratories, L.p.$191
- plus $1K from 15 others
What the payments were for
- Food & beverage$2,906100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 13 | $459 |
| AbbVie | 18 | $451 |
| Johnson & Johnson(2 entities) | 14 | $354 |
| Lilly USA, LLC | 4 | $204 |
| Sun Pharmaceutical Industries Inc. | 5 | $199 |
| Galderma Laboratories, L.p. | 12 | $191 |
| Novartis | 7 | $173 |
| Amgen | 7 | $163 |
| Dermavant Sciences, Inc. | 3 | $154 |
| Pfizer | 2 | $136 |
| Almirall LLC | 5 | $101 |
| Strata Skin Sciences, Inc. | 1 | $77 |
| LEO Pharma Inc. | 3 | $66 |
| Incyte Corporation | 3 | $61 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $20 |
| Organogenesis Inc. | 1 | $18 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
| VYNE Pharmaceuticals Inc. | 1 | $15 |
| Kerecis Limited | 1 | $13 |
| Verrica Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,906 in reported general payments places this provider in the 55th percentile of 37 mohs-micrographic surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 24 | $904 |
| Doxycycline Monohydrate | 41 | $622 |
| Cephalexin | 175 | $524 |
| Triamcinolone Acetonide | 25 | $152 |
| Mupirocin | 16 | $152 |
| Clindamycin Hcl | 33 | $68 |
| Diazepam | 21 | $19 |
| Amoxicillin | 13 | $12 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Centennial
- Matthew MahlbergCentennial$1K
- Joel CohenGreenwood Village$426K
- Shawn AllenBoulder$69K
- Kevin MottLoveland$33K
- Karen NernEdwards$28K
- Vinh ChungColorado Springs$10K
- Brett MathesonColorado Spgs$10K
- Misha MillerDenver$5K
- Joseph WildeFort Collins$5K
- Samantha GhiselliGlendale$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.